Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design

Heerajnarain Bulluck, Georg M. Fröhlich, Shah Mohdnazri, Reto A. Gamma, John R. Davies, Gerald J. Clesham, Jeremy W. Sayer, Rajesh K. Aggarwal, Kare H. Tang, Paul A. Kelly, Rohan Jagathesan, Alamgir Kabir, Nicholas M. Robinson, Alex Sirker, Anthony Mathur, Daniel J. Blackman, Cono Ariti, Arvindra Krishnamurthy, Steven K. White, Pascal Meier, James C. Moon, John P. Greenwood, Derek J. Hausenloy
  • Clinical Cardiology, May 2015, Wiley
  • DOI: 10.1002/clc.22401

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Heeraj Bulluck